selective Rac1/1b GTPase nucleotide binding inhibitors (Exonhit)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameselective Rac1/1b GTPase nucleotide binding inhibitors (Exonhit)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRas-related C3 botulinum toxin substrate 1 inhibitors
TargetsRas-related C3 botulinum toxin substrate 1
Therapy Area/IndicationsAlzheimer DiseaseNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEurobio Scientific
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEurobio Scientific
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A